President Donald Trump’s tariffs have two primary objectives. One is to rebalance the world trade order, which he believes is ...

Shares in pharmaceuticals giant Eli Lilly (LLY) were looking perkier today after it ramped up its battle to get a key ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

One man’s trash may be another man’s treasure, but dumpster diving when investing carries risks. You have to wade through a ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

Citigroup dropped their price objective on Eli Lilly and Company from $1,250.00 to $1,190.00 and set a “buy” rating on the stock in a report on Tuesday, January 28th. Bank of America ...

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

The results could be harmful to them in more ways than one. Despite this issue, Eli Lilly remains a top stock to buy. As everyone who follows equity markets knows, stocks are feeling the heat from ...

On Tuesday, Goldman Sachs (NYSE:GS) upgraded shares of Eli Lilly (NYSE:LLY) from Neutral to Buy, while slightly reducing the price target to $888 from $892. The firm’s analyst highlighted the ...